Company intelligence / Profile preview
Conba Pharmaceutical
Hangzhou, Zhejiang, Chinaconbapharm.com ↗
- Ownership
- Private
- Employees
- ~8400
- Development stage
- Commercial
01
Overview
Conba Pharmaceutical has a broad commercial portfolio spanning traditional Chinese medicines and modern pharmaceuticals. It has approved products for cardiovascular disease (SheXiangTongXin dropping pills), acne vulgaris (azelaic acid), frailty syndrome (Zhigancao Tang granule), bacterial infections (azlocillin sodium targeting PBPs), and urethral diseases (flavoxate hydrochloride targeting ORAI1). The company also holds exclusive rights in China to develop EVT 401—a P2X7 antagonist for inflammatory conditions—licensed from Evotec. Clinical trials are ongoing or planned for new indications and compounds.
- Therapeutic areas
- Men's HealthImmunologyOtherDermatologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeHerbal medicine (Traditional Chinese Medicine)Synthetic peptideBiologic
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Request access →03
Partnerships
Evotec AG – exclusive license for EVT401 in China for inflammatory indications
Beyond the preview
Go deeper on Conba Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Conba Pharmaceutical.